Guardant Health Inc (GH)
18.64
-0.19
(-1.01%)
USD |
NASDAQ |
May 08, 16:00
18.64
0.00 (0.00%)
After-Hours: 18:06
Guardant Health Research and Development Expense (TTM): 367.19M for Dec. 31, 2023
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 367.19M |
| September 30, 2023 | 383.92M |
| June 30, 2023 | 390.08M |
| March 31, 2023 | 385.18M |
| December 31, 2022 | 373.81M |
| September 30, 2022 | 340.25M |
| June 30, 2022 | 311.20M |
| March 31, 2022 | 289.47M |
| December 31, 2021 | 263.22M |
| September 30, 2021 | 230.48M |
| June 30, 2021 | 195.76M |
| March 31, 2021 | 168.35M |
| Date | Value |
|---|---|
| December 31, 2020 | 149.86M |
| September 30, 2020 | 135.46M |
| June 30, 2020 | 123.78M |
| March 31, 2020 | 106.99M |
| December 31, 2019 | 86.29M |
| September 30, 2019 | 77.07M |
| June 30, 2019 | 66.75M |
| March 31, 2019 | 58.78M |
| December 31, 2018 | 50.71M |
| September 30, 2018 | 42.18M |
| June 30, 2018 | 35.18M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
66.75M
Minimum
Jun 2019
390.08M
Maximum
Jun 2023
233.95M
Average
230.48M
Median
Sep 2021
Research and Development Expense (TTM) Benchmarks
| Exact Sciences Corp | 425.88M |
| Illumina Inc | 1.353B |
| Delcath Systems Inc | 17.50M |
| CytoSorbents Corp | 15.73M |
| Progyny Inc | -- |